Comments on “Ochratoxin A: In utero Exposure in Mice Induces Adducts in Testicular DNA. Toxins 2010, 2, 1428–1444”—Mis-Citation of Rat Literature to Justify a Hypothetical Role for Ochratoxin A in Testicular Cancer by Mantle, Peter G.
Toxins 2010, 2, 2333-2336; doi:10.3390/toxins2102333 
 
toxins
ISSN 2072-6651 
www.mdpi.com/journal/toxins 
Commentary 
Comments on “Ochratoxin A: In utero Exposure in Mice Induces 
Adducts in Testicular DNA. Toxins 2010, 2, 1428–1444”— 
Mis-Citation of Rat Literature to Justify a Hypothetical Role for 
Ochratoxin A in Testicular Cancer 
Peter G. Mantle  
Centre for Environmental Policy, Imperial College London, South Kensington, London, SW7 2AZ, UK; 
E-Mail: p.mantle@imperial.ac.uk; Tel.: +44-207-594-5245 
Received: 2 September 2010; in revised form: 9 September 2010 / Accepted: 21 September 2010 /  
Published: 29 September 2010  
 
Abstract:  A manuscript in the journal recently cited experimental rat data from two 
manuscripts to support plausibility of a thesis that ochratoxin A might be a cause of human 
testicular cancer. I believe that there is no experimental evidence that ochratoxin A 
produces testicular cancer in rats or mice.  
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In the introduction of the manuscript in question, a claim for direct evidence of a carcinogenic role 
for ochratoxin A (OTA) in the testis is made by citing [1], in which 25% of male rats given the toxin 
during the second year of life developed testis tumors. However, the experiment had no untreated 
animals because the limited objective was to compare duration of OTA exposure on renal 
carcinogenesis. Further, citation of [2] as corroborative evidence for testis carcinogenesis was even 
more unfortunate because it was clearly stated there that testis tumors occurred equally in treated rats 
and in controls. Instead, authors should have cited both the most comprehensive source of data for 
OTA toxicology in the rat [3], in which no evidence of additional testicular tumorigenesis attributable 
to the toxin was found, and the lifetime study in the mouse [4]. The latter, in which extensive 
histopathological study of necropsy tissues was also made, found no testis tumors in controls and none 
also even at the very high dietary OTA concentration of 40 ppm for up to two years. In kidney,  
OTA-generated tumors were abundant (50%) in the 40 ppm dietary regimen group, but only in males, 
and none was found in a 1 ppm regimen group. 
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Thus, the literature clearly states that OTA did not cause testicular tumors in rats, or in mice even 
when high dose exposure severely constrained growth [3] and provided approximately six times more 
daily OTA exposure than in [5] without causing testis tumors. Further support comes indirectly from a 
more recent NTP study on fumonisin B1 [6], in which testicular cancer was naturally common in 
ageing control male rats and similarly so in response to increasing exposure to that toxin. Also, there 
were no testis tumors in male mice. Consequently, at the end of the discussion in [5], it is incorrect to 
use the findings to explain origin of the natural testis tumors described in [1] and [2]. 
Consequently, the unfortunate mis-citation of [1] and [2] leaves a role for OTA in human testicular 
cancer unsupported by model animal experiments and still needing DNA adduct data to show whether 
there are any vascularized tissues in which adducts are not found. A simple pattern of one or two rat 
kidney adducts has been shown by 
32P post-labeling in response to OTA [7]. The dominant one has 
been characterized as a covalent DNA adduct between the des-chloro-analogue of OTA and guanine, 
and its potential to cause genetic change via subsequent mis-repair has been recognized [7]. However, 
the significance of greater complexity of some adduct patterns in [5] remains to be elucidated. The 
justification for a hypothesis that OTA might cause testicular cancer [5] includes reference to Balkan 
endemic nephropathy (BEN), and “high levels of OTA-contamination of food” in the Balkans. 
However, increased incidence of testicular cancer has not been recognized as associated with the 
bilateral renal atrophy of BEN nor of the transitional cell carcinomas in the upper urinary tract which 
are sometimes associated with BEN. If exceptional significant exposure to OTA is associated with 
either the renal atrophy or the urinary tract tumors, there should have been a concomitant increase in 
testicular cancer if human testes have a propensity to respond adversely to circulating OTA. Also, a 
difference of <1 µg in the mean daily individual intake of OTA, between BEN and non-BEN 
households [8], can hardly justify “high level” as a descriptor of BEN household intake. Further, on a 
body weight basis, mean daily OTA intake (1.2 µg) in BEN households [8] was ~500 times less than 
that causing just 2 adducts/10
9 nucleotides in mouse testis [5]. It is therefore very difficult to see 
experimental evidence supporting the original hypothesis which suggested that OTA could be a cause 
of human testicular cancer [9].  
Rat seminomas associated with exposure to OTA have not previously been illustrated, probably 
because no etiological significance of the toxin was attributed in the NTP study [5]. Figure 1 shows 
testis histopathology in a two-year-old rat, euthanized prematurely because of a large, age-related, 
subcutaneous tumor after 90 weeks of exposure to OTA at twice the mean daily rate of the highest 
dose in the NTP study [5]. A steady plasma OTA concentration of ~11.4 µg/mL was achieved [10] and 
the cumulative OTA dose was >70 mg. Bi-lateral renal tumors, typically attributed to the dietary OTA 
exposure regimen, also occurred, and confirmed the carcinogenicity of OTA in this animal. There was 
no confounding clinical or histopathological evidence of the mononuclear leukemia to which F 344 
rats are prone. This testis tissue, and that of others in my archive of tumorous testis tissue of defined 
experimental OTA provenance, can be available for further study if requested. Toxins 2010, 2  
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Figure 1. Two regions of a testis of an F 344 rat, which ingested OTA (300 µg/kg body 
weight) daily in feed for 90 weeks, in a longitudinal section (1.0 × 1.8 cm) stained with 
hematoxylin and eosin showing vascularized seminomas amongst ageing seminiferous 
tubules. A causal association is not implied for the toxin because testicular tumor is natural 
in some ageing rats.  
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